How can diabetic ketoacidosis (DKA) be differentiated from hyperosmolar hyperglycemic state (HHS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Differentiating DKA from HHS

DKA and HHS are differentiated primarily by three key laboratory values: blood glucose level, pH/bicarbonate, and the presence or absence of ketones.

Diagnostic Criteria

DKA Criteria 12:

  • Blood glucose ≥250 mg/dL
  • Venous pH <7.3
  • Bicarbonate <15 mEq/L
  • Moderate to severe ketonuria or ketonemia

HHS Criteria 1:

  • Blood glucose ≥600 mg/dL (significantly higher than DKA)
  • Venous pH ≥7.3 (no significant acidosis)
  • Bicarbonate ≥15 mEq/L
  • Minimal or absent ketones
  • Altered mental status or severe dehydration

Key Distinguishing Features

The Critical Differences:

Glucose threshold: HHS presents with much more severe hyperglycemia (≥600 mg/dL vs ≥250 mg/dL). This is the most immediately apparent difference on initial labs 1.

Ketosis and acidosis: DKA is characterized by significant ketone production and metabolic acidosis, while HHS has minimal to no ketones and preserved pH 11. The pathophysiologic explanation is that HHS patients retain enough residual insulin (C-peptide) to prevent lipolysis and ketogenesis, but not enough to control glucose 11.

Time course: HHS typically evolves over days to weeks, whereas DKA develops more rapidly, often within 24 hours 1.

Mental status: While both can present with altered consciousness, profound mental status changes and coma are more characteristic of HHS due to extreme hyperosmolarity 1.

Clinical Presentation Patterns

DKA typically presents with:

  • Kussmaul respirations (deep, rapid breathing)
  • Fruity breath odor (acetone)
  • Abdominal pain and vomiting
  • Younger patients, more common in type 1 diabetes 13

HHS typically presents with:

  • Profound dehydration
  • Neurological symptoms (confusion, lethargy, focal deficits)
  • Older patients, more common in type 2 diabetes 14

Important Caveats

Mixed presentations occur: Approximately one-third of cases show overlapping features with both ketoacidosis and hyperosmolarity present 45. Don't rely solely on glucose thresholds—always check pH, bicarbonate, and ketones 5.

Mortality differences: HHS carries a significantly higher mortality rate (15%) compared to DKA (5%), largely due to older patient age, comorbidities, and delayed presentation 113.

Ketone measurement: Use β-hydroxybutyrate (β-OHB) blood measurement rather than nitroprusside urine testing, as the latter only detects acetoacetate and acetone, not the predominant ketone body in DKA 1. During treatment, β-OHB converts to acetoacetate, which can falsely suggest worsening ketosis on urine testing.

Practical Laboratory Algorithm

  1. Check blood glucose immediately: >600 mg/dL suggests HHS
  2. Obtain venous pH and bicarbonate: pH <7.3 and HCO₃ <15 mEq/L indicates DKA
  3. Measure serum or urine ketones: Significant ketonemia/ketonuria confirms DKA
  4. Calculate serum osmolality: Severe hyperosmolarity (>320 mOsm/kg) supports HHS 6
  5. Assess anion gap: Elevated in DKA due to ketoacids 2

The diagnosis is not mutually exclusive—treat based on the dominant metabolic derangement present, recognizing that management principles overlap significantly between the two conditions 17.

Related Questions

What are the differences in clinical presentation, laboratory findings, and management between hyperosmolar hyperglycemic state (HHS) and diabetic ketoacidosis (DKA)?
In a patient with a serum glucose of 390 mg/dL, normal anion gap (12), normal bicarbonate (CO₂ 24 mm Hg), and intact mental status, does this represent diabetic ketoacidosis, hyperglycemic hyperosmolar state, or uncontrolled diabetes?
In a patient with serum glucose 390 mg/dL, anion gap 12, and bicarbonate (CO₂) 25 mmol/L, does this indicate diabetic ketoacidosis or hyperosmolar hyperglycemic state, and is the patient's mental status normal?
What are the diagnostic criteria for diabetic ketoacidosis (DKA) and hyperglycemic hyperosmolar syndrome (HHS) in patients with a history of diabetes mellitus?
In a diabetic patient non‑adherent to therapy with a blood glucose of 500 mg/dL but without diabetic ketoacidosis (DKA) or hyperosmolar hyperglycemic state (HHS), how should this episode be classified and why does it require hospital admission?
In a postpartum patient with a suspected 1 cm ventral hernia at a cesarean incision, should MRI be used instead of high‑frequency abdominal wall ultrasound to differentiate the hernia from postoperative scar tissue?
What is the maximum dose of propranolol (Inderal) for treating tachycardia in an adult?
Can a patient with alanine aminotransferase 104 U/L, aspartate aminotransferase 54 U/L, and triglycerides 305 mg/dL safely receive Ilumya (tildrakizumab)?
What is the appropriate prescription regimen for amoxicillin‑clavulanic acid 500 mg/125 mg?
What is the appropriate management of hemoptysis in a patient with hilar adenocarcinoma?
In a patient with a three‑month intermittent productive cough, normal chest X‑ray and normal laboratory studies, is montelukast an appropriate therapy?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.